Test ID: TXBU
11-Dehydro-Thromboxane B2, Urine
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
83335
Useful For Suggests clinical disorders or settings where the test may be helpful
Determining increased risk of coronary heart disease and stroke
Identifying patients most likely to benefit from antiplatelet therapy
Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)
| Test ID | Test Number | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|---|
| AACT | 10064 | Creatinine, U | No | Yes |
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
When 11-dehydro-thromboxane B2 testing is performed, AACT/10064 Creatinine, Urine will always be performed at no additional charge.
Method Name A short description of the method used to perform the test
TXBU/83335: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
AACT/10064: Enzymatic Colorimetric Assay
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
11-Dehydro-Thromboxane B2, U
Aliases Lists additional common names for a test, as an aid in searching
*Anti-Platelet Therapy
*Aspirin Effect
*Aspirin Resistance
*Aspirin Therapy
*Platelet Activation
*Platelet Aggregation
*Platelet Inhibition
*Note: These key words are related to how other manufacturers use the 11-dehydro-thromboxane B2 analyte. Utilization of this test for these purposes is not the intent of this assay.
*Aspirin Effect
*Aspirin Resistance
*Aspirin Therapy
*Platelet Activation
*Platelet Aggregation
*Platelet Inhibition
*Note: These key words are related to how other manufacturers use the 11-dehydro-thromboxane B2 analyte. Utilization of this test for these purposes is not the intent of this assay.
External
link
PDF
document
Excel
document
Word
document